E
ZYUS Life Sciences Corporation ZYUS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 332.30K 315.90K 287.00K 260.10K 244.10K
Total Other Revenue -- -- -- -- --
Total Revenue 332.30K 315.90K 287.00K 260.10K 244.10K
Cost of Revenue 1.75M 1.77M 1.76M 1.74M 485.10K
Gross Profit -1.42M -1.46M -1.47M -1.48M -240.90K
SG&A Expenses 8.43M 9.02M 9.64M 9.45M 7.97M
Depreciation & Amortization 2.19M 2.23M 2.15M 2.30M 2.27M
Other Operating Expenses 279.80K 285.50K 291.60K 261.10K 202.30K
Total Operating Expenses 14.22M 14.46M 14.78M 14.72M 11.68M
Operating Income -13.89M -14.14M -14.49M -14.46M -11.43M
Income Before Tax -31.16M -31.41M -34.77M -35.87M -18.03M
Income Tax Expenses -4.29M -4.30M -4.30M -4.30M -43.80K
Earnings from Continuing Operations -26.86 -27.12 -30.47 -31.57 -17.99
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -26.86M -27.12M -30.47M -31.57M -17.99M
EBIT -13.89M -14.14M -14.49M -14.46M -11.43M
EBITDA -12.00M -12.21M -12.64M -12.45M -9.52M
EPS Basic -0.38 -0.39 -0.49 -0.54 -0.40
Normalized Basic EPS -0.13 -0.13 -0.17 -0.21 -0.23
EPS Diluted -0.39 -0.39 -0.49 -0.55 -0.40
Normalized Diluted EPS -0.13 -0.13 -0.17 -0.21 -0.23
Average Basic Shares Outstanding 283.92M 281.56M 256.46M 224.14M 192.64M
Average Diluted Shares Outstanding 283.92M 281.56M 256.46M 224.14M 192.64M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings